PECAM1 and neoplasm: In the absence of gemcitabine, PAK4KO did not affect the expression of CD31 (Figure 3f), CD34 (Figure 3g) or fibronectin (Figure 3h), suggesting that PAK4KO did not affect the angiogenesis within the tumour in this xenograft SCID mouse model.